Taylor Douglas K
Division of Animal Resources, Emory University, Atlanta, Georgia;, Email:
Comp Med. 2019 Dec 1;69(6):501-509. doi: 10.30802/AALAS-CM-19-000002. Epub 2019 Jul 17.
Mice and rats are valuable and commonly used as models for the study of cancer. The models and methods of experimentation have the potential to cause pain to some degree, and all charged with ensuring animal welfare must determine how to manage it. A commonly posed question, especially from investigators and IACUC, is whether the provision of analgesic agents will render the model invalid. Left untreated, pain is a stressor and has negative consequences, most notably immune system perturbations. In addition, analgesic agents in the opioid and NSAID drug classes exhibit immunomodulatory activity and influence processes such as cell proliferation, apoptosis, and angiogenesis that are important in cancer formation. Therefore, both pain and the agents used to alleviate it have the potential to act as confounding factors in a study. This review article presents data from both human medicine and work with animal models in an attempt to help inform discussions about the withholding of analgesic agents from animals used in cancer studies.
小鼠和大鼠是研究癌症的常用且有价值的模型。实验模型和方法在某种程度上有可能导致疼痛,而所有负责确保动物福利的人员都必须确定如何应对。一个常见的问题,尤其是来自研究人员和机构动物护理与使用委员会(IACUC)的问题是,给予镇痛剂是否会使模型无效。若不进行治疗,疼痛是一种应激源,会产生负面后果,最显著的是免疫系统紊乱。此外,阿片类和非甾体抗炎药(NSAID)类的镇痛剂具有免疫调节活性,并会影响细胞增殖、凋亡和血管生成等在癌症形成中很重要的过程。因此,疼痛和用于缓解疼痛的药物都有可能在研究中成为混杂因素。这篇综述文章展示了来自人类医学和动物模型研究的数据,试图为关于在癌症研究中不给动物使用镇痛剂的讨论提供参考。